凯瑞德
(002072)
| 流通市值：13.46亿 | | | 总市值：19.30亿 |
| 流通股本：2.56亿 | | | 总股本：3.68亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 5,565,358.8 | 27,042,458.93 | 3,224,717.55 | 2,611,420.57 |
| 结算备付金 | - | - | 0 | 0 |
| 拆出资金 | - | - | 0 | 0 |
| 衍生金融资产 | - | - | 0 | 0 |
| 应收票据及应收账款 | 38,691,014.13 | 27,201,756.54 | 23,202,789.13 | 34,767,581.04 |
| 其中：应收票据 | 100,000 | - | 0 | 0 |
| 应收账款 | 38,591,014.13 | 27,201,756.54 | 23,202,789.13 | 34,767,581.04 |
| 应收款项融资 | - | - | 0 | 0 |
| 预付款项 | 11,138,839.56 | 14,376,818.54 | 12,445,907.62 | 20,163,993.61 |
| 应收保费 | - | - | 0 | 0 |
| 应收分保账款 | - | - | 0 | 0 |
| 应收分保合同准备金 | - | - | 0 | 0 |
| 其他应收款合计 | 1,168,891.84 | 1,496,954.26 | 16,104,003.8 | 16,055,394.27 |
| 其中:应收利息 | - | - | 0 | 0 |
| 应收股利 | - | - | 0 | 0 |
| 买入返售金融资产 | - | - | 0 | 0 |
| 存货 | 20,946,465.06 | 34,931,887.92 | 40,102,714.03 | 27,770,961.51 |
| 合同资产 | - | - | 0 | 0 |
| 一年内到期的非流动资产 | 1,213,089.34 | - | 0 | 0 |
| 其他流动资产 | 2,949,025.29 | 2,922,337.9 | 955,457.05 | 1,501,238.5 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 102,767,841.48 | 107,972,214.09 | 107,000,682.08 | 113,780,307.24 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | 0 | 0 |
| 债权投资 | - | - | 0 | 0 |
| 其他债权投资 | - | - | 0 | 0 |
| 长期应收款 | - | - | 0 | 0 |
| 长期股权投资 | - | - | 0 | 0 |
| 其他权益工具投资 | - | - | 0 | 0 |
| 其他非流动金融资产 | - | - | 0 | 0 |
| 投资性房地产 | - | - | 0 | 0 |
| 固定资产 | 821,939.87 | 584,478.3 | 611,307.94 | 641,835.73 |
| 在建工程 | - | - | 0 | 0 |
| 生产性生物资产 | - | - | 0 | 0 |
| 油气资产 | - | - | 0 | 0 |
| 使用权资产 | 1,060,478.29 | 2,802,881.23 | 1,596,930.76 | 2,107,279.08 |
| 无形资产 | - | - | 0 | 0 |
| 开发支出 | - | - | 0 | 0 |
| 商誉 | - | - | 0 | 0 |
| 长期待摊费用 | 357,109.7 | 403,739.43 | 439,275.18 | 480,788.61 |
| 递延所得税资产 | 275,897.58 | 303,447.67 | 89,052.59 | 118,755.68 |
| 其他非流动资产 | - | - | 0 | 0 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,515,425.44 | 4,094,546.63 | 2,736,566.47 | 3,348,659.1 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 105,283,266.92 | 112,066,760.72 | 109,737,248.55 | 117,128,966.34 |
| 流动负债: | | | | |
| 短期借款 | - | - | 0 | 0 |
| 向中央银行借款 | - | - | 0 | 0 |
| 吸收存款及同业存放 | - | - | 0 | 0 |
| 拆入资金 | - | - | 0 | 0 |
| 交易性金融负债 | - | - | 0 | 0 |
| 衍生金融负债 | - | - | 0 | 0 |
| 应付票据及应付账款 | 2,449,792.76 | 10,291,155.06 | 3,151,936.14 | 820,067.89 |
| 其中：应付票据 | - | - | 0 | 0 |
| 应付账款 | 2,449,792.76 | 10,291,155.06 | 3,151,936.14 | 820,067.89 |
| 预收款项 | - | - | 0 | 0 |
| 合同负债 | 6,407,619.12 | - | 0 | 10,217,328.94 |
| 卖出回购金融资产款 | - | - | 0 | 0 |
| 应付手续费及佣金 | - | - | 0 | 0 |
| 应付职工薪酬 | 342,672.95 | 311,786.84 | 309,951.01 | 833,177.27 |
| 应交税费 | 1,027,356.96 | 1,079,119.19 | 313,816.99 | 1,887,899.54 |
| 其他应付款合计 | 40,631,100.47 | 38,518,854.94 | 48,523,662.82 | 47,974,950.78 |
| 其中:应付利息 | - | - | 0 | 0 |
| 应付股利 | - | - | 0 | 0 |
| 应付分保账款 | - | - | 0 | 0 |
| 保险合同准备金 | - | - | 0 | 0 |
| 代理买卖证券款 | - | - | 0 | 0 |
| 代理承销证券款 | - | - | 0 | 0 |
| 一年内到期的非流动负债 | 1,103,590.35 | 1,090,842.96 | 234,690.01 | 231,965.41 |
| 其他流动负债 | 2,309,354.29 | 2,377,869.61 | 2,226,615.85 | 1,328,252.76 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 54,271,486.9 | 53,669,628.6 | 54,760,672.82 | 63,293,642.59 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 0 | 0 |
| 应付债券 | - | - | 0 | 0 |
| 优先股 | - | - | 0 | 0 |
| 永续债 | - | - | 0 | 0 |
| 租赁负债 | - | 122,947.71 | 121,520.36 | 243,057.3 |
| 长期应付款 | - | - | 0 | 0 |
| 长期应付职工薪酬 | - | - | 0 | 0 |
| 预计负债 | 3,566.65 | 3,847.87 | 121,517.75 | 121,517.75 |
| 递延收益 | - | - | 0 | 0 |
| 递延所得税负债 | 325,515.6 | 445,956.63 | 137,207.94 | 255,220.8 |
| 其他非流动负债 | - | - | 0 | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 329,082.25 | 572,752.21 | 380,246.05 | 619,795.85 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 54,600,569.15 | 54,242,380.81 | 55,140,918.87 | 63,913,438.44 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 367,680,000 | 367,680,000 | 367,680,000 | 367,680,000 |
| 其他权益工具 | - | - | 0 | 0 |
| 优先股 | - | - | 0 | 0 |
| 永续债 | - | - | 0 | 0 |
| 资本公积 | 655,455,805.18 | 655,455,805.18 | 655,455,805.18 | 655,455,805.18 |
| 减:库存股 | 218,733,406.81 | 218,733,406.81 | 218,733,664.41 | 218,733,664.41 |
| 其他综合收益 | - | - | 0 | 0 |
| 专项储备 | - | - | 0 | 0 |
| 盈余公积 | 38,257,186.79 | 38,257,186.79 | 38,257,186.79 | 38,257,186.79 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | -791,976,887.39 | -784,835,205.25 | -788,062,997.88 | -789,443,799.66 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 50,682,697.77 | 57,824,379.91 | 54,596,329.68 | 53,215,527.9 |
| 少数股东权益 | - | - | 0 | 0 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 50,682,697.77 | 57,824,379.91 | 54,596,329.68 | 53,215,527.9 |
| 负债和股东权益合计 | 105,283,266.92 | 112,066,760.72 | 109,737,248.55 | 117,128,966.34 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |